XS
SGMO

XR Securities’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

XR Securities’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,200
Closed -$36K – 569
2020
Q4 		$36K Buy
+12,200
New +$143K ﹤0.01% 330
2020
Q3 		– Sell
-34,700
Closed -$32K – 345
2020
Q2 		$32K Buy
34,700
+22,800
+192% +$212K ﹤0.01% 197
2020
Q1 		$15K Buy
11,900
+1,600
+16% +$11.9K ﹤0.01% 179
2019
Q4 		$1K Sell
10,300
-1,100
-10% -$10.1K ﹤0.01% 232
2019
Q3 		$4K Sell
11,400
-300
-3% -$3.37K ﹤0.01% 220
2019
Q2 		$12K Buy
+11,700
New +$124K ﹤0.01% 226
2019
Q1 		– Sell
-10,000
Closed -$17K – 395
2018
Q4 		$17K Sell
10,000
-5,600
-36% -$69.6K 0.01% 266
2018
Q3 		$58K Buy
+15,600
New +$237K 0.02% 238

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return